Apoptosis:: the link between autoantibodies and leuko-/lymphocytopenia in patients with lupus erythematosus

被引:21
作者
Böhm, I [1 ]
机构
[1] Univ Bonn, Dept Radiol, D-53105 Bonn, Germany
关键词
D O I
10.1080/03009740410006907
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To analyse the relation between serum autoantibodies and leuko-/lymphocytopenia in patients with lupus erythematosus ( LE). Methods: Laboratory routine analyses (white blood cell counts, autoantibody detection), and flow cytometry (annexin V, CD3, CD4, CD8, CD95, F(ab) 2 anti-human IgG) have been performed in LE-patients versus healthy controls. In vitro, the influence of pooled serum containing anti-dsDNA antibodies has been analysed on the CD95 expression. Results: Leukocytes, lymphocytes, CD3+, CD3+ CD4+, and CD3+ CD8+ cells from LE-patients were significantly reduced compared with controls. Patients with autoantibodies had significantly lower absolute cell counts than those without. Apoptosis was increased in LE versus controls (p<0.04). The percentage of CD95+ T-cells was increased, and the absolute number of CD95+ cells was reduced in LE. In vitro up-regulation of CD95 could be detected on T-cells of healthy donors. Induction of CD95 seems to be donor-dependent. Conclusion: The data suggest that autoantibodies may be associated with blood cytopenias. CD95 seems to play a central role in this signalling cascade. The underlying mechanism is unclear, but seems to be autoantibody-related apoptosis induction.
引用
收藏
页码:409 / 416
页数:8
相关论文
共 41 条
  • [1] ACTIVATION MARKERS ON PERIPHERAL-BLOOD T-CELLS FROM PATIENTS WITH ACTIVE OR INACTIVE SYSTEMIC LUPUS-ERYTHEMATOSUS - CORRELATION WITH PROLIFERATIVE RESPONSES AND PRODUCTION OF IL-2
    ALCOCERVARELA, J
    ALARCONRIQUELME, M
    LAFFON, A
    SANCHEZMADRID, F
    ALARCONSEGOVIA, D
    [J]. JOURNAL OF AUTOIMMUNITY, 1991, 4 (06) : 935 - 945
  • [2] AMASAKI Y, 1995, CLIN EXP IMMUNOL, V99, P245
  • [3] Do elevated levels of serum-soluble Fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
    Bijl, M
    van Lopik, T
    Limburg, PC
    Spronk, PE
    Jaegers, SMHJ
    Aarden, LA
    Smeenk, RJT
    Kallenberg, GGM
    [J]. JOURNAL OF AUTOIMMUNITY, 1998, 11 (05) : 457 - 463
  • [4] Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus (SLE): relation to lymphocyte activation and disease activity
    Bijl, M
    Horst, G
    Limburg, PC
    Kallenberg, CGM
    [J]. LUPUS, 2001, 10 (12) : 866 - 872
  • [5] Anti-CD3-induced and anti-Fas-induced apoptosis in systemic lupus erythematosus (SLE)
    Bijl, M
    Horst, G
    Limburg, PC
    Kallenberg, CGM
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 123 (01) : 127 - 132
  • [6] Disruption of the cytoskeleton after apoptosis induction with autoantibodies
    Böhm, I
    [J]. AUTOIMMUNITY, 2003, 36 (03) : 183 - 189
  • [7] Bohm Ingrid, 2003, Mol Imaging Biol, V5, P2, DOI 10.1016/S1536-1632(03)00024-6
  • [8] Spontaneous and induced apoptosis in systemic lupus erythematosus: Multiple assays fail to reveal consistent abnormalities
    Caricchio, R
    Cohen, PL
    [J]. CELLULAR IMMUNOLOGY, 1999, 198 (01) : 54 - 60
  • [9] Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis
    Casiano, CA
    Martin, SJ
    Green, DR
    Tan, EM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) : 765 - 770
  • [10] Lymphocyte apoptosis in systemic lupus erythematosus: relationships with Fas expression, serum soluble Fas and disease activity
    Courtney, PA
    Crockard, AD
    Williamson, K
    McConnell, J
    Kennedy, RJ
    Bell, AL
    [J]. LUPUS, 1999, 8 (07) : 508 - 513